Commerce and Industry Minister calls for coordinated efforts to simplify regulations, improve funding access, expedite patent approvals and strengthen indigenous procurement and research infrastructure.
New Delhi : Union Minister for Commerce and Industry Shri Piyush Goyal held discussions with representatives of India’s biopharmaceutical and biotechnology startup ecosystem to understand key challenges facing the sector and explore opportunities to accelerate its growth.
During the interaction, the Minister discussed the need for coordinated action to simplify regulatory processes, improve access to funding, expedite patent approvals and strengthen indigenous procurement mechanisms. He also highlighted the importance of developing robust research infrastructure to support innovation and enable startups to translate their ideas into market-ready solutions.
The discussions focused on addressing bottlenecks that often affect emerging companies in the biotechnology and biopharma sectors, particularly in areas such as regulatory compliance, financing, intellectual property protection, research and development, and access to procurement opportunities.
Shri Goyal emphasised that stronger collaboration among the government, industry and research institutions would be essential to create a supportive ecosystem for innovation. Such partnerships can help startups overcome operational challenges, expand their research capabilities, attract investment and scale their businesses.
India’s biopharmaceutical and biotechnology sectors have significant potential to contribute to healthcare innovation, advanced research, manufacturing capabilities and high-value employment. Strengthening the startup ecosystem in these areas is also important for building domestic technological capabilities and reducing dependence on external sources.
The Minister noted that closer coordination among all stakeholders would help innovative startups grow, strengthen India’s biotechnology ecosystem and contribute meaningfully to the country’s expanding bioeconomy.